Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) | |||||
ATC code: J07BB02 | |||||
Document link: | |||||
Document date: | |||||
Study number: GID18 | |||||
EudraCT number: EUDRACT 200... | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |